SCHEMBL8554591

SCHEMBL8554591

O=C1c2ccccc2C(=O)N1CCCCCOc1ccccc1

nearest known ligand 0.87

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.87
MAPT P10636 2/20 0.87
SMN1; SMN2 Q16637 1/20 0.87
HPGD P15428 2/20 0.62
NPSR1 Q6W5P4 1/20 0.62
TDP1 Q9NUW8 2/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
NPC1 O15118 1/20 0.60
KMT2A Q03164 1/20 0.56
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C19 P33261 1/20 0.55
LMNA P02545 1/20 0.55
PKM P14618 1/20 0.55
ALDH1A1 P00352 1/20 0.55
ACHE P22303 4/20 0.54
KCNA3 P22001 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11996369 1.00 RAB9A (0.87) RAB9AMAPTSMN1; SMN2HPGDNPSR1
SCHEMBL1999435 0.98 RAB9A (0.90) RAB9AMAPTSMN1; SMN2HPGDNPSR1
SCHEMBL7299163 0.93 RAB9A (1.00) RAB9AMAPTSMN1; SMN2HPGDNPSR1
SCHEMBL10683824 0.91 RAB9A (0.72) RAB9AMAPTSMN1; SMN2HPGDNPSR1
SCHEMBL10682756 0.91 RAB9A (0.72) RAB9AMAPTSMN1; SMN2HPGDNPSR1
SCHEMBL10675533 0.91 RAB9A (0.72) RAB9AMAPTSMN1; SMN2HPGDNPSR1
SCHEMBL10680795 0.91 RAB9A (0.72) RAB9AMAPTSMN1; SMN2HPGDNPSR1
SCHEMBL10675006 0.91 RAB9A (0.72) RAB9AMAPTSMN1; SMN2HPGDNPSR1
SCHEMBL10683303 0.91 RAB9A (0.72) RAB9AMAPTSMN1; SMN2HPGDNPSR1
SCHEMBL10680450 0.91 RAB9A (0.72) RAB9AMAPTSMN1; SMN2HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0840725-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1998-05-13 EP disclosed
WO-1997002242-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-01-23 WO disclosed